Sfoglia per Autore
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC)
2021 Petrocelli, Giovannamaria; Farabegoli, Fulvia; Valerii, Maria Chiara; Giovannini, Catia; Sardo, Alberto; Spisni, Enzo
Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy
2022 Farabegoli, Fulvia; Pinheiro, Marina
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement
2022 Carmen Ciavarella, Ilenia Motta, Santino Blando, Sabrina Valente, Fulvia Farabegoli, Maria Letizia Focarete, Mauro Gargiulo, Gianandrea Pasquinelli
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells
2022 Rossi V.; Govoni M.; Farabegoli F.; Di Stefano G.
Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines
2022 Farabegoli F.; Granja A.; Magalhaes J.; Purgato S.; Voltattorni M.; Pinheiro M.
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination
2022 Schipani, Fabrizio; Manerba, Marcella; Marotta, Roberto; Poppi, Laura; Gennari, Arianna; Rinaldi, Francesco; Armirotti, Andrea; Farabegoli, Fulvia; Roberti, Marinella; Di Stefano, Giuseppina; Rocchia, Walter; Girotto, Stefania; Tirelli, Nicola; Cavalli, Andrea
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer
2023 Laura Poppi, Samuel H Myers, Viola Previtali, Francesco Rinaldi, Fulvia Farabegoli, Giuseppina Di Stefano, Naomi Walsh, Marinella Roberti, Andrea Cavalli
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer
2023 Myers S. H., Poppi L., Rinaldi F., Veronesi M., Ciamarone A., Previtali V., Bagnolini G., Schipani F., Ortega Martínez J. A., Girotto S., Di Stefano G., Farabegoli F., Walsh N., De Franco F., Roberti M., Cavalli A.
Large Population Of Homogeneous Spheroids Models For Testing Toxicity And Diffusion Of Nanomaterials
2023 Emanuela Mensà, Ottavia Tartagni, Fulvia Farabegoli, Renato Brandimarti, Dario De Biase, Giampaolo Zuccheri
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) | Petrocelli, Giovannamaria; Farabegoli, Fulvia; Valerii, Maria Chiara; Giovannini, Catia; Sardo, A...lberto; Spisni, Enzo | 2021-01-01 | MOLECULES | - | 1.01 Articolo in rivista | molecules-26-00885.pdf |
| Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy | Farabegoli, Fulvia; Pinheiro, Marina | 2022-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | fphar-13-809706.pdf |
| Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement | Carmen Ciavarella, Ilenia Motta, Santino Blando, Sabrina Valente, Fulvia Farabegoli, Maria Letizi...a Focarete, Mauro Gargiulo, Gianandrea Pasquinelli | 2022-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-10-01276-v2.pdf |
| Lactate is a potential promoter of tamoxifen resistance in MCF7 cells | Rossi V.; Govoni M.; Farabegoli F.; Di Stefano G. | 2022-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | - | 1.01 Articolo in rivista | - |
| Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines | Farabegoli F.; Granja A.; Magalhaes J.; Purgato S.; Voltattorni M.; Pinheiro M. | 2022-01-01 | ACS OMEGA | - | 1.01 Articolo in rivista | acsomega.2c01829(2022).pdf |
| The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination | Schipani, Fabrizio; Manerba, Marcella; Marotta, Roberto; Poppi, Laura; Gennari, Arianna; Rinaldi,... Francesco; Armirotti, Andrea; Farabegoli, Fulvia; Roberti, Marinella; Di Stefano, Giuseppina; Rocchia, Walter; Girotto, Stefania; Tirelli, Nicola; Cavalli, Andrea | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-23-08338-v3 (1).pdf |
| A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer | Laura Poppi, Samuel H Myers, Viola Previtali, Francesco Rinaldi, Fulvia Farabegoli, Giuseppina Di... Stefano, Naomi Walsh, Marinella Roberti, Andrea Cavalli | 2023-01-01 | - | FEBS PRESS | 4.03 Poster | - |
| An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer | Myers S. H., Poppi L., Rinaldi F., Veronesi M., Ciamarone A., Previtali V., Bagnolini G., Schipan...i F., Ortega Martínez J. A., Girotto S., Di Stefano G., Farabegoli F., Walsh N., De Franco F., Roberti M., Cavalli A. | 2023-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Large Population Of Homogeneous Spheroids Models For Testing Toxicity And Diffusion Of Nanomaterials | Emanuela Mensà, Ottavia Tartagni, Fulvia Farabegoli, Renato Brandimarti, Dario De Biase, Giampaol...o Zuccheri | 2023-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile